Guidance for industry : pre-storage leukocyte reduction of whole blood and blood compoments intended for transfusion.
Saved in:
Imprint: | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2001] |
---|---|
Description: | i, 22 pages : digital, PDF file |
Language: | English |
Subject: | |
Format: | E-Resource U.S. Federal Government Document Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/7732183 |
Varying Form of Title: | Pre-storage leukocyte reduction of whole blood and blood compoments intended for transfusion |
---|---|
Other authors / contributors: | Center for Biologics Evaluation and Research (U.S.) |
Notes: | Title from PDF title page (viewed on May 29, 2009). "Draft -- not for implementation". "January, 2001". Includes bibliographical references (pages 19-22). Mode of access: Internet at the FDA CBER web site. Address as of 5/29/09: http://www.fda.gov/cber/gdlns/preleuk.pdf ; current access is available via PURL. |
GPO item no.: | 0499-T-02 (online) |
Govt.docs classification: | HE 20.4802:L 57 |
Similar Items
-
Clinical benefits of leukodepleted blood products /
Published: (1995) -
Controversies of leukocyte-poor blood and components /
Published: (1989) -
Toxic granulation in leukocytes, development and relation to cloudy swelling.
by: Gordin, Ruben
Published: (1952) -
Guidance for industry : adequate and appropriate donor screening for hepatitis b : hepatitis b surface antigen (HBsAg) assays used to test donors of whole blood and blood components, including source plasma and source leukocytes.
Published: (2007) -
Separation of leucocytes from blood and bone marrow. With special reference to factors which influence and modify sedimentation properties of hematopoietic cells.
by: Böyum, Arne, 1928-
Published: (1968)